Skip to the answer

Estradiol / Norethindrone Uses, Dosage, Side Effects and Interactions

Brand names
Lopreeza

Lopreeza is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.

Activella

Activella was the first estradiol / norethindrone product the FDA approved, in November 1998. An FDA-approved generic with the same active ingredients is listed.

Etyqa

Etyqa is a generic estradiol / norethindrone sold under its own name, approved by the FDA in June 2023. An FDA-approved generic with the same active ingredients is listed.

Abigale

Abigale is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.

Abigale Lo

Abigale Lo is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.

Mimvey

Mimvey is a brand of estradiol / norethindrone that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.

Amabelz

Amabelz is a generic estradiol / norethindrone sold under its own name, approved by the FDA in June 2016. It is not in the FDA’s directory today; generic estradiol / norethindrone is.

Estradiol / norethindrone is a combination estrogen and progestin hormone therapy used to treat moderate to severe menopausal symptoms and to help prevent postmenopausal osteoporosis.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Estradiol / NorethindroneType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Estradiol / Norethindrone in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Estradiol / norethindrone is a long-standing combined hormone therapy for women with a uterus, treating moderate to severe hot flashes and vaginal dryness from menopause and helping prevent bone thinning; estradiol replaces lost estrogen while norethindrone, a progestin, protects the uterine lining, and it has been on the U.S. market since about 1998 with FDA-approved generics listed. Most women tolerate it reasonably well, and breast tenderness and spotting are what people notice most, often in the first months. Its boxed warning covers blood clots, stroke, heart attack, breast cancer and, from age 65, probable dementia, so use the lowest dose that works for as short a time as needed. Review at every checkup whether you still need it.

Key Takeaways From the HelloPharmacist Team

  • Take the tablet once a day, with or without food; the patch version is changed twice a week, rotating where you place it.
  • Expect some spotting or breast tenderness early on, but get any unexplained or new vaginal bleeding checked promptly.
  • Get emergency care for sudden leg pain or swelling, chest pain, shortness of breath, trouble speaking, or sudden vision loss.
  • Stay current on mammograms and report any new breast lump, since this combination raises breast cancer risk.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Estradiol / Norethindrone.

This medicine carries a serious FDA boxed warning about cancer, heart problems, and dementia. Taking estrogen plus progestin has been linked to a higher risk of heart attack, stroke, blood clots (deep vein thrombosis and pulmonary embolism), and invasive breast cancer. Studies in women 65 and older also found a higher risk of probable dementia. Do not use this medicine to prevent heart disease, stroke, or dementia — it is not approved for those purposes and may actually increase those risks. Using estrogen alone (without a progestin) in women who still have a uterus raises the risk of uterine (endometrial) cancer. The risks of estrogen plus progestin therapy were studied primarily with one specific product and dose; how much these risks apply to other products and doses, including this one, is not fully known. Talk with your doctor regularly about whether the benefits still outweigh the risks for you personally.

Read the full warning on DailyMed →

Estradiol / Norethindrone by the Numbers

Strengths
4
across 2 forms
Makers and packagers
10
Earliest FDA record
1998
Rank by Medicaid prescriptions
#685 of 1,682 drugs
More prescriptions than 59% of the 1,682 drugs we measure
40,957 prescriptions, Q1–Q4 2025

Patient Information Guide for Estradiol / Norethindrone

What It’s Used For

Estradiol / norethindrone is a combination hormone therapy approved for postmenopausal women who still have a uterus. Here is the full set of supported uses across available products:

  • Moderate to severe vasomotor symptoms (hot flashes, night sweats) due to menopause — supported by all oral tablet products and CombiPatch
  • Moderate to severe vulvar and vaginal atrophy symptoms (dryness, irritation, painful intercourse) due to menopause — supported by all oral tablet products and CombiPatch; topical vaginal products should be considered first if this is the only reason for treatment
  • Prevention of postmenopausal osteoporosis (bone thinning after menopause) — supported by oral tablet products; non-estrogen medications should be considered first if osteoporosis prevention is the sole reason for use, and estrogen should be reserved for women at significant risk
  • CombiPatch (the transdermal patch) is additionally approved for treatment of low estrogen due to hypogonadism (underactive ovaries), castration, or primary ovarian failure

How It Works

After menopause, estrogen levels drop sharply. Estradiol is the main active estrogen in the body — it binds to estrogen receptors in tissues like the brain, vagina, and bone, helping to ease hot flashes, reverse vaginal changes, and slow the bone loss that follows menopause. Norethindrone acetate is a progestin (a synthetic progesterone-like hormone) that balances estrogen's effects on the uterine lining, reducing the risk of abnormal tissue growth (endometrial hyperplasia) that can develop when estrogen is used alone.

The progestin component works by binding to progesterone receptors, which counteract estrogen's stimulating effect on the uterus and help reduce estrogen receptor activity in target tissues.

Drug Class

Drug Class

  • Estrogen from estradiol
  • Progestin from norethindrone
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Estradiol / Norethindrone has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Estrogen from estradiol
  • Progestin from norethindrone

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Estrogen Receptor Agonists from estradiol

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Estradiol / Norethindrone in the FDA’s index.

From our Patient Information GuideAfter menopause, estrogen levels drop sharply. Estradiol is the main active estrogen in the body — it binds to estrogen receptors in tissues like the brain, vagina, and bone, helping to ease hot flashes, reverse vaginal changes, and slow the bone loss that follows menopause. Read How Estradiol / Norethindrone Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Estradiol Congeners from estradiol
  • Progesterone Congeners from norethindrone

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Natural and semisynthetic estrogens, plain from estradiol
  • Progestogens from norethindrone
  • Estren derivatives from norethindrone

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Oral tablets are taken once daily by mouth. Taking the tablet with food does not meaningfully affect how estradiol is absorbed, though it may slightly alter the absorption profile of norethindrone.

CombiPatch (the transdermal patch) is applied to the skin twice weekly on a rotating site. All forms should be used at the lowest dose that controls your symptoms, for the shortest time that meets your goals — your doctor should reassess this at regular visits.

  • Oral tablets: once daily, with or without food
  • CombiPatch: applied to skin, changed twice weekly, rotating sites
  • Never adjust your dose on your own — always follow your prescriber's instructions

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Estradiol / Norethindrone Skin Patch

Menopause symptoms in women with a uterus
Women with a uterus · Continuous combined regimen Apply one system to the lower abdomen twice weekly; a new system every 3 to 4 days (twice weekly) during a 28-day cycle, continuous uninterrupted treatment
Women with a uterus · Continuous sequential regimen Starting dose 0.05 mg per day of estradiol (Vivelle-Dot patch) every 3 to 4 days for the first 14 days Usual dose 1 patch (0.05 mg estradiol/0.14 mg NETA per day) every 3 to 4 days for the remaining 14 days

Step by step

  1. Days 1 to 14 of a 28-day cycle: 0.05 mg per day estradiol transdermal system (Vivelle-Dot), replaced every 3 to 4 days (twice weekly)
  2. Remaining 14 days: CombiPatch 0.05 mg estradiol/0.14 mg NETA per day (9 cm2) worn continuously on the lower abdomen, replaced every 3 to 4 days (twice weekly)
Good to Know for Every Dose

0.05 mg estradiol/0.25 mg NETA (16 cm2 system) is available if a greater progestin dose is desired

See the Full Dosing Instructions on DailyMed →

Estradiol / Norethindrone Taken by Mouth

Hot flashes and night sweats from menopause
For women after menopause
Usual dose 1 tablet once a day
Vaginal and vulvar dryness and thinning from menopause
For women after menopause
Usual dose 1 tablet (1 mg/0.5 mg) once a day
Preventing bone thinning after menopause
For women after menopause
Usual dose 1 tablet once a day

See the Full Dosing Instructions on DailyMed →

Side Effects

The most commonly reported side effects with oral estradiol / norethindrone acetate tablets include:

Common side effects

  • Breast pain or tenderness
  • Headache
  • Nausea
  • Back pain
  • Vaginal bleeding or spotting
  • Upper respiratory tract infections
  • Insomnia
  • Weight gain
  • Vaginal bleeding or spotting after menopause
  • Sinus congestion (sinusitis)
  • Emotional changes or mood swings

When to get medical help

  • Signs of blood clot: sudden leg pain or swelling, chest pain, shortness of breath, or coughing up blood — seek emergency care immediately
  • Signs of stroke: sudden numbness, severe headache, trouble speaking, or vision changes — call 911
  • Signs of heart attack: chest pain, pain spreading to the arm or jaw, sweating — call 911
  • Sudden partial or complete vision loss — stop the medicine and get medical help right away
  • Unusual lumps in the breast or changes on mammogram — tell your doctor
  • Unexplained vaginal bleeding — contact your doctor promptly
  • Severe allergic reaction (swelling of the face, lips, tongue, or throat, hives, difficulty breathing) — seek emergency care

Warnings and Precautions

  • Blood clots, stroke, and heart attack: Estrogen plus progestin therapy raises the risk of DVT (deep vein thrombosis), PE (pulmonary embolism), stroke, and heart attack. Stop this medicine immediately and seek emergency care if you develop sudden leg pain or swelling, chest pain, shortness of breath, or signs of stroke. Estrogen should be stopped at least 4 to 6 weeks before major surgery or extended bed rest.
  • Breast cancer: Combined estrogen plus progestin therapy has been linked to an increased risk of invasive breast cancer. Get yearly breast exams and mammograms as recommended. Report any new breast lumps to your doctor.
  • Uterine (endometrial) cancer: Using estrogen without a progestin in women who have a uterus increases endometrial cancer risk. The norethindrone in this combination helps reduce — but does not eliminate — that risk. Report any unexpected vaginal bleeding to your doctor promptly.
  • Ovarian cancer: Hormone therapy has been associated with a modestly increased risk of ovarian cancer based on study data.
  • Dementia: In women 65 and older, combined hormone therapy was linked to a higher risk of probable dementia. This medicine should not be used to prevent dementia.
  • Gallbladder disease: Estrogen therapy raises the risk of gallbladder disease requiring surgery by 2 to 4 times.
  • Liver disease: Do not use if you have active liver disease. Stop the medicine if cholestatic jaundice (yellowing of the skin due to bile flow problems) occurs.
  • Vision changes: Retinal vascular thrombosis (a blood clot in the eye) has been reported. Stop the medicine and get an eye exam immediately if you have sudden vision loss or eye pain.

Interactions

Several medicines and supplements can raise or lower hormone levels when taken with estradiol / norethindrone:

  • St. John's wort (herbal supplement) — speeds up hormone breakdown, which can lower hormone levels and reduce effectiveness or cause irregular bleeding
  • Seizure medicines (phenobarbital, carbamazepine) and rifampin (antibiotic) — also speed up breakdown of estradiol and norethindrone, potentially reducing their effect
  • Antifungal medicines (ketoconazole, itraconazole) and antibiotics (erythromycin, clarithromycin) — slow hormone breakdown, which can raise levels and increase side effects
  • Ritonavir (HIV medicine) — may increase hormone levels in the blood
  • Grapefruit juice — may raise estradiol levels by slowing its breakdown in the gut and liver

Interactions Listed in the FDA-Approved Label

From the Estradiol / Norethindrone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • CYP3A4 inducers (St. John's wort, phenobarbital, carbamazepine, rifampin)
    What happensMay reduce plasma concentrations of estrogens, possibly decreasing therapeutic effects and/or changing the uterine bleeding profile.
  • CYP3A4 inhibitors (erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, grapefruit juice)
    What happensMay increase plasma concentrations of estrogens and result in adverse reactions.
  • Drugs or herbal products that induce or inhibit cytochrome P-450 enzymes, including CYP3A4 (norethindrone acetate)
    What happensMay decrease or increase the serum concentrations of norethindrone.
Read the label’s full interactions text

7 DRUG INTERACTIONS Co-administration of estradiol with norethindrone acetate did not elicit any apparent influence on the pharmacokinetics of norethindrone acetate. Similarly, no relevant interaction of norethindrone acetate on the pharmacokinetics of estradiol was found within the NETA dose range investigated in a single dose study. Estradiol In-vitro and in-vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4). Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4 such as St. John’s wort ( Hypericum perforatum ) preparations, phenobarbital, carbamazepine, and rifampin may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile. Inhibitors of CYP3A4 such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may increase plasma concentrations of estrogens and result in adverse reactions. Norethindrone Acetate Drugs or herbal products that induce or inhibit cytochrome P-450 enzymes, including CYP3A4, may decrease or increase the serum concentrations of norethindrone. Inducers and/or inhibitors of CYP3A4 may affect estrogen drug metabolism and decrease or increase the estrogen plasma concentration.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if you have unexplained or undiagnosed vaginal bleeding
  • Do not use if you have or have had breast cancer, or other estrogen-dependent cancers
  • Do not use if you have active blood clots (DVT or PE) or a history of them
  • Do not use if you have had a stroke or heart attack, or have active arterial blood clot disease
  • Do not use if you have active liver disease or liver impairment
  • Do not use if you have an inherited clotting disorder (protein C, protein S, or antithrombin deficiency, or other thrombophilic conditions)
  • Do not use if you have had a severe allergic reaction (anaphylaxis or angioedema) to this medicine
  • Women 65 and older face higher risks of stroke, breast cancer, and probable dementia — discuss carefully with your doctor
  • Not for use during pregnancy or in children
  • Tell your doctor if you are breastfeeding — this medicine passes into breast milk and may reduce milk supply
  • Tell your doctor if you take thyroid replacement hormone — estrogen can affect thyroid function tests and may require dose adjustments of thyroid medicine

Overdose

Taking too much of this medicine may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness, fatigue, and possibly unexpected vaginal bleeding. If an overdose is suspected, stop taking the medicine and contact a healthcare provider or poison control center for guidance on appropriate care.

How Your Body Processes It

After swallowing an oral tablet, estradiol is absorbed through the gastrointestinal tract and reaches peak blood levels within about 5 to 8 hours; norethindrone acetate is quickly converted to norethindrone and peaks within about 30 to 90 minutes. With daily dosing, steady-state blood levels are reached within about two weeks. Both hormones are mostly bound to proteins in the blood (albumin and SHBG) and are broken down primarily in the liver. Estradiol is metabolized into estrone and estriol, which are less active, and both estradiol and norethindrone are eventually excreted in urine and bile. Food does not significantly change how much estradiol is absorbed from the tablet, but it does modestly alter the absorption profile of norethindrone.

Storage

Store in a dry place protected from light. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Estradiol / Norethindrone: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Estradiol / Norethindrone — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is this medicine doing for me — why do I need both an estrogen and a progestin?

Great question. The estradiol (the estrogen part) is what actually relieves your hot flashes, night sweats, and vaginal dryness by replacing the estrogen your body stopped making after menopause. The norethindrone (the progestin part) is there to protect your uterus. Estrogen on its own can cause the uterine lining to thicken over time, which increases the risk of uterine cancer. The progestin counteracts that effect, so taking both together is much safer for your uterus than estrogen alone.

What are the most important side effects I should actually watch out for?

Most women notice things like breast tenderness, some spotting or light bleeding, headaches, or nausea — especially in the first few months. Those are common and usually settle down. What you really need to call about right away are signs of a blood clot — like sudden leg swelling or pain, chest pain, or trouble breathing — or signs of a stroke, like sudden face drooping, arm weakness, or slurred speech. Also report any sudden vision changes or new breast lumps to your doctor without delay.

I've heard hormone therapy can cause cancer. How worried should I be?

It's a real concern worth taking seriously, but it's also about weighing risks and benefits. Combined estrogen plus progestin therapy has been linked to a modestly increased risk of breast cancer and may slightly increase ovarian cancer risk. On the flip side, the progestin in this medicine helps protect against uterine cancer, which estrogen alone would raise. The goal is to use the lowest dose that controls your symptoms for the shortest time needed, and to check in with your doctor regularly. Annual breast exams and mammograms are important while you're on this medicine.

Are there any supplements or medications I should avoid while taking this?

Yes — a few things can interfere. St. John's wort, a popular herbal supplement, can lower your hormone levels and make the medicine less effective or cause irregular bleeding. Some prescription medicines — including certain seizure medications, the antibiotic rifampin, and some HIV medicines like ritonavir — can also reduce how well it works. On the flip side, certain antifungals and antibiotics like clarithromycin can raise your hormone levels. Even grapefruit juice can increase estradiol in your system. Always tell every healthcare provider what you're taking, including supplements.

How long will I need to take this, and will I know when to stop?

There's no one-size-fits-all answer. The guidance is to use the lowest dose that helps for the shortest time that makes sense for you personally. Your doctor should check in with you regularly — at least once a year — to decide whether you still need it. Some women take it for a year or two to get through the worst of menopause; others may need it longer. The decision should always be based on how your symptoms are, how you're tolerating it, and your individual health risks. You and your doctor make that call together.

Is it safe to take this if I'm over 65?

You can still use it, but the risks are higher for older women and worth a careful conversation with your doctor. Studies in women 65 to 79 years old found higher rates of stroke, breast cancer, and probable dementia with combined hormone therapy compared to placebo. If you're over 65 and still need symptom relief, your doctor should use the lowest effective dose and reassess regularly. This medicine should never be used simply to prevent heart disease or dementia — the evidence shows it doesn't help with those and may actually cause harm.

Is estradiol / norethindrone available over the counter?

No. Estradiol / norethindrone is a prescription medicine: every estradiol / norethindrone product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was estradiol / norethindrone first available?

The earliest FDA record we hold for estradiol / norethindrone is from 1998: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when estradiol / norethindrone was first used.

Who makes estradiol / norethindrone?

10 companies currently list estradiol / norethindrone products in the FDA's NDC Directory, including Amneal Pharmaceuticals NY LLC, A-S Medication Solutions, Amneal Pharmaceuticals LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of estradiol / norethindrone?

Estradiol / norethindrone is the generic name. Its brand names are Lopreeza, Activella, Etyqa, Abigale, Abigale Lo and 2 more. Generic versions are listed under the name estradiol / norethindrone.

What is the generic name of Lopreeza?

The generic name of Lopreeza is estradiol / norethindrone. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is estradiol / norethindrone?

Estradiol / norethindrone belongs to the drug class Estrogen and Progestin, its established pharmacologic class on the FDA label.

Is there a generic version of estradiol / norethindrone?

Yes. FDA-approved generic versions of estradiol / norethindrone are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does estradiol / norethindrone come in?

Estradiol / norethindrone is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 0.5 mg/0.1 mg and 1 mg/0.5 mg. Skin patch (through the skin): 0.05 mg/d / 0.14 mg/d and 0.05 mg/d / 0.25 mg/d. A listing does not mean every pharmacy stocks every strength.

How much does estradiol / norethindrone cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.55 to $0.59 per generic tablet across 2 strengths and $31.79 to $31.80 each for the skin patch of the brand-name version across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the estradiol / norethindrone prescribing information (package insert)?

The full FDA-approved prescribing information for estradiol / norethindrone, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Amneal Pharmaceuticals LLC's, revised Nov 30, 2023, and links to it on DailyMed.

Is estradiol / norethindrone gluten free?

No estradiol / norethindrone label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 20 estradiol / norethindrone products from 10 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's estradiol / norethindrone by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See estradiol / norethindrone inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Estradiol / Norethindrone

Skip the scrolling. Ask in your own words and get an answer from Estradiol / Norethindrone’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Estradiol / Norethindrone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Estradiol / Norethindrone on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Estradiol / Norethindrone Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Estradiol / Norethindrone Forms and Strengths (How It Comes)

Estradiol / Norethindrone comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Estradiol / Norethindrone inactive ingredients by manufacturer.

Tablet

By mouth
Brands Lopreeza Activella (the first brand, 1998) Etyqa (2023) Abigale Abigale Lo Mimvey Amabelz (2016, not listed today)
How this form is used
What it may be used for
  • Treats moderate to severe hot flashes and night sweats (vasomotor symptoms) due to menopause
  • Treats moderate to severe vaginal dryness and irritation (vulvar and vaginal atrophy) due to menopause
  • Helps prevent postmenopausal osteoporosis (bone loss after menopause)
  • Indicated for women who still have a uterus — the progestin component helps protect the uterine lining
Important instructions
  • Abigale, Abigale Lo, Activella, and other oral tablets are taken once daily by mouth
  • Tablets may be taken with or without food; taking with food may slightly reduce the peak level of norethindrone but does not meaningfully change overall absorption of estradiol
  • Use the lowest effective dose for the shortest duration consistent with your treatment goals — discuss regularly with your doctor
  • Do not stop or adjust your dose without talking to your prescriber first
Available strengths 2 strengths
18 FDA-listed product records ⓘ

Skin patch

Through the skin
How this form is used
What it may be used for
  • CombiPatch treats moderate to severe vasomotor symptoms (hot flashes, night sweats) due to menopause
  • CombiPatch treats moderate to severe symptoms of vulvar and vaginal atrophy due to menopause
  • CombiPatch is indicated for low estrogen levels caused by hypogonadism (underactive ovaries), castration, or primary ovarian failure
  • CombiPatch is indicated for women with a uterus; when used only for vaginal symptoms, topical vaginal products should be considered first
Important instructions
  • CombiPatch is applied to the skin (transdermal) and worn continuously; apply twice weekly
  • CombiPatch should be started at the lowest dose; your prescriber will determine the appropriate regimen
  • Rotate the application site with each new patch to avoid skin irritation
  • CombiPatch should be used at the lowest effective dose for the shortest duration — your doctor should reassess your need for treatment periodically
Available strengths 2 strengths
2 FDA-listed product records ⓘ

Estradiol / Norethindrone on the U.S. Market: Products, Makers and Brands

How Estradiol / Norethindrone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

10 companies list 20 Estradiol / Norethindrone product records with the FDA, mostly as tablet, skin patch; the earliest marketing or approval year on record is 1998. Brand names in the directory today include Lopreeza, Activella, Etyqa and 3 more; the rest are generics.

2
Dose forms ⓘ
10
Labelers (makers, repackagers, distributors)
7
Brand names ⓘ
20
FDA-listed product records ⓘ
1998
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Amneal Pharmaceuticals NY LLC20%
A-S Medication Solutions10%
Amneal Pharmaceuticals LLC10%
Aurobindo Pharma Limited10%
Breckenridge Pharmaceutical, Inc.10%
Ingenus Pharmaceuticals, LLC10%
Other makers30%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Estradiol / Norethindrone Is Used (Medicaid Data)

How many Estradiol / Norethindrone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

40,957
Medicaid prescriptions filled (Q1–Q4 2025)
$8.6M paid by Medicaid, before rebates

How commonly is Estradiol / Norethindrone prescribed? Of the 1,682 medications we measure, Estradiol / Norethindrone ranks #685 by Medicaid prescriptions — more than 59% of them.

Where Estradiol / Norethindrone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Estradiol / Norethindrone product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 0.00208 mg/HR / 0.00583 mg/HR 84 hr transdermal system is the most-dispensed Estradiol / Norethindrone product — about 45% of these Medicaid prescriptions.

84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System Most dispensed

18,446 Medicaid prescriptions (Q1–Q4 2025) 45% of Estradiol / Norethindrone prescriptions shown $5.9M paid by Medicaid, before rebates ≈ $321 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 1251493

84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System

6,300 Medicaid prescriptions (Q1–Q4 2025) 15% of Estradiol / Norethindrone prescriptions shown $2.1M paid by Medicaid, before rebates ≈ $326 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 1251499

Other Estradiol / Norethindrone products: packs and listings not matched to one strength and form

16,211 Medicaid prescriptions (Q1–Q4 2025) 40% of Estradiol / Norethindrone prescriptions shown $622,922 paid by Medicaid, before rebates ≈ $38 per prescription, before rebates

11 of 34 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 13 of the 38 listed Estradiol / Norethindrone NDCs had Medicaid claims.

Compare Estradiol / Norethindrone Products

A representative set of FDA-listed product records for Estradiol / Norethindrone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 20 of 20 products — FDA National Drug Code Directory.

Estradiol / Norethindrone Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Estradiol / Norethindrone — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Estradiol / Norethindrone are breast cancer, breast cancer female, fatigue; about 74% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

1,984
Reports mentioning it
74%
Reported as serious
12
Distinct effects shown
Most reported effects
Breast Cancer
283
Breast Cancer Female
191
Fatigue
101
Nausea
101
Headache
83
Dizziness
76
Pain
69
Feeling Abnormal
60
Arthralgia
59
Diarrhoea
59
Age groups
Adult · 143Elderly · 24Neonate · 2

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Estradiol / Norethindrone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Estradiol / Norethindrone FDA Approval History

How Estradiol / Norethindrone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Estradiol / Norethindrone was first approved by the FDA in 1998. It remains available in U.S. pharmacies today.

1998
First FDA approval
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Estradiol / Norethindrone Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Estradiol / Norethindrone recalls since July 2021.

✅No Estradiol / Norethindrone recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Estradiol / Norethindrone in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
2
Strengths
7
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Estradiol / Norethindrone RxCUI 214551
  1. Dose form (SCDF) Oral Tablet RxCUI 372073
    In current FDA listings
    Its 4 strengths (SCD)
  2. Dose form (SCDF) Transdermal System RxCUI 1806052
    In current FDA listings
    Its 3 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Estradiol / Norethindrone Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Estradiol / Norethindrone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form and a strength to see how its price has changed since Nov 2023.

Form
Strength

For the generic ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg tablet, pharmacies paid an average of $0.593 per tablet as of Nov 18, 2026, down 20% from $0.741 a year earlier.

What pharmacies pay now
$0.593
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 17%
from $0.712 on Oct 21, 2026
Last 12 months
Down 20%
from $0.741 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.405 to $0.967
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.593
Oct 2026$0.712
Sep 2026$0.802
Aug 2026$0.883
Jul 2026$0.898
Jun 2026$0.809
May 2026$0.691
Apr 2026$0.678
Mar 2026$0.759
Feb 2026$0.967
Jan 2026$0.919
Dec 2025$0.817
Nov 2025$0.741
Oct 2025$0.816
Sep 2025$0.884
Aug 2025$0.791
Jul 2025$0.708
Jun 2025$0.624
May 2025$0.590
Apr 2025$0.600
Mar 2025$0.735
Feb 2025$0.697
Jan 2025$0.618
Dec 2024$0.529
Nov 2024$0.405
Oct 2024$0.689
Sep 2024$0.661
Aug 2024$0.691
Jul 2024$0.428
Jun 2024$0.715
May 2024$0.491
Apr 2024$0.555
Mar 2024$0.639
Feb 2024$0.665
Jan 2024$0.846
Dec 2023$0.663
Nov 2023$0.681
FormStrengthVersion What pharmacies pay
Tablet · Oral ESTRADIOL 0.5 mg/1; NORETHINDRONE ACETATE 0.1 mg Generic $0.593 per tablet NDC details & price history
Tablet · Oral ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE 0.5 mg Generic $0.549 per tablet NDC details & price history
Skin patch · Transdermal ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.14 mg/d Brand name $31.80 each NDC details & price history
Skin patch · Transdermal ESTRADIOL 0.05 mg/d; NORETHINDRONE ACETATE 0.25 mg/d Brand name $31.79 each NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Estradiol / Norethindrone Brand Names

Estradiol / Norethindrone has 7 brand names on record: Lopreeza, Activella, Etyqa, Abigale and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Lopreeza Activella the first brand, 1998 Etyqa 2023 Abigale Abigale Lo Mimvey Amabelz 2016, not listed today

Who Makes Estradiol / Norethindrone: Manufacturers and Labelers

10 companies list Estradiol / Norethindrone products with the FDA. By number of product records, the largest are Amneal Pharmaceuticals NY LLC, A-S Medication Solutions, Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Amneal Pharmaceuticals NY LLC 4 A-S Medication Solutions 2 Amneal Pharmaceuticals LLC 2 Aurobindo Pharma Limited 2 Breckenridge Pharmaceutical, Inc. 2 Ingenus Pharmaceuticals, LLC 2 Noven Therapeutics, LLC 2 Xiromed LLC 2 Naari Pte. Limited 1 Teva Pharmaceuticals USA, Inc. 1

Sources for This Estradiol / Norethindrone Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Nov 30, 2023, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Estradiol / Norethindrone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
12
Finished products in the current FDA directory
20
Companies listing them (makers, repackagers, distributors)
10
FDA labeler codes behind them ⓘ
10
Linked representative label ⓘ
Amneal Pharmaceuticals LLC
Linked label effective
Nov 30, 2023
Composite sections available
27
Linked SPL Set ID
d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0
Linked SPL Document ID
ec312506-ea70-4aa1-8c07-0347fe956a57
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amneal Pharmaceuticals LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →